FDA Inspection 854419 — Akron General Medical Center Institutional Research Review Board

Akron General Medical Center Institutional Research Review Board — FEI 1526259

The FDA completed an inspection of Akron General Medical Center Institutional Research Review Board on November 7, 2013 in Akron, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Akron, OH (United States)

Additional Details

IRB

Citations

IDCFRDescription
728121 CFR 56.108(a)(1)Initial and continuing reviews
731821 CFR 56.115(a)(2)Minutes of IRB meetings
733421 CFR 56.115(a)(5)List of members
737021 CFR 56.111(c)Children as subjects